HOFF, SABINE,ROSE, LARS,ZOPF, DIETER,KIESSLING, FABIAN,LEDERLE, WILTRUD,DOLESCHEL, DENNIS
申请号：
CA3065125
公开号：
CA3065125A1
申请日:
2018.05.25
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention relates to pharmaceutical compositions and combinationscomprising regorafenib or its hydrate,solvate, metabolite or pharmaceutically acceptable salt or a polymorph thereofand a PD-1/PD-L1(2) inhibitor for treating, preventingor managing diseases and conditions including hyperproliferative disorderssuch as cancer in humans and other mammals.
